✦ LIBER ✦

A phase II study using teniposide (VM26) alone as first line therapy in elderly patients (PTS) affected by Small Cell Lung Cancer (SCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unexpected high toxicity in a phase II s

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Unexpected high toxicity in a phase II s

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Unexpected high toxicity in a phase II s

✍ Cerny, T.; Pedrazzini, A.; Joss, R.A.; Brunner, K.W. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 390 KB

A phase II study of paclitaxel (P) and c

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Topotecan (Hycamtin™) in small cell lung

✍ von Pawel, J.; Deplerre, A.; Hans, K.; Moro, D.; Clark, P.; Gatzerneier, U.; Pai 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Single agent oral topotecan (OT) as firs

✍ Eckardt, J.R; Palmer, M.C; Fanucchi, M.P; Gralla, R; Martins, H; Poulin, R; Fiel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB